Epitope characterization and crystal structure of GA101 provide insights into the molecular basis for the type I / type II distinction of anti- CD20 antibodies
Domain Annotation: SCOP/SCOPe Classification SCOP-e Database Homepage
Domain Annotation: ECOD Classification ECOD Database Homepage
| Chains | Family Name | Domain Identifier | Architecture | Possible Homology | Homology | Topology | Family | Provenance Source (Version) |
|---|---|---|---|---|---|---|---|---|
| D [auth K] | Globin | e3pp3K1 | A: alpha bundles | X: Lipocalins/Streptavidin | H: Zn-dependent exopeptidases | T: Zn-dependent exopeptidases | F: Globin | ECOD (develop294) |
| B [auth L] | Globin | e3pp3L1 | A: alpha bundles | X: Lipocalins/Streptavidin | H: Zn-dependent exopeptidases | T: Zn-dependent exopeptidases | F: Globin | ECOD (develop294) |
| C [auth I] | Globin | e3pp3I1 | A: alpha bundles | X: Lipocalins/Streptavidin | H: Zn-dependent exopeptidases | T: Zn-dependent exopeptidases | F: Globin | ECOD (develop294) |
| A [auth H] | I-set | e3pp3H1 | A: alpha bundles | X: Acyl-CoA binding protein-like | H: Acyl-CoA binding protein-like | T: Acyl-CoA binding protein-like | F: I-set | ECOD (develop294) |
Domain Annotation: CATH CATH Database Homepage
| Chain | Domain | Class | Architecture | Topology | Homology | Provenance Source (Version) |
|---|---|---|---|---|---|---|
| D [auth K] | 2.60.40.10 | Mainly Beta | Sandwich | Immunoglobulin-like | Immunoglobulins | CATH (4.3.0) |
| B [auth L] | 2.60.40.10 | Mainly Beta | Sandwich | Immunoglobulin-like | Immunoglobulins | CATH (4.3.0) |
| C [auth I] | 2.60.40.10 | Mainly Beta | Sandwich | Immunoglobulin-like | Immunoglobulins | CATH (4.3.0) |
| A [auth H] | 2.60.40.10 | Mainly Beta | Sandwich | Immunoglobulin-like | Immunoglobulins | CATH (4.3.0) |
IMGT Antibody Annotation IMGT Database Homepage
| Chain | Protein Name | Description | Organism Name | Gene Allele Name(s) | Domain Name(s) | Receptor Type | Receptor Description | Provenance Source |
|---|---|---|---|---|---|---|---|---|
| B [auth L], D [auth K] | INN name | L-KAPPA | Humanized (humanized) | IGKV2-28*01, IGKV2D-28*01, IGKJ4*01, IGKJ4*02, IGKC*01 | V-DOMAIN V-KAPPA, C-DOMAIN C-KAPPA | IG | FAB-GAMMA-1_KAPPA | IMGT (202610-0) |
| A [auth H], C [auth I] | INN name | VH-CH1 | Humanized (humanized) | IGHV1-69*02, IGHV1-69*04, IGHV1-69*08, IGHV1-69*09, IGHJ5*01, IGHG1*01, IGHG1*02, IGHG1*04 | V-DOMAIN VH, C-DOMAIN CH1 | IG | FAB-GAMMA-1_KAPPA | IMGT (202610-0) |
SAbDab Antibody Annotation SAbDab Database Homepage
| Chain | Chain Class | Chain Subclass | Chain Type | Antigen Name(s) | Provenance Source |
|---|---|---|---|---|---|
| B [auth L], D [auth K] | Light Chain | IGKV2D | Kappa | - | SAbDab (2026-03-20) |
| A [auth H], C [auth I] | Heavy Chain | IGHV1 | - | - | SAbDab (2026-03-20) |
Thera-SAbDab Antibody Annotation Thera-SAbDab Database Homepage
| Chain | Name | Target | Provenance Source |
|---|---|---|---|
| B [auth L], D [auth K] | Obinutuzumab | MS4A1/CD20 | Therapeutic SAbDab (2026-03-20) |
| A [auth H], C [auth I] | Obinutuzumab | MS4A1/CD20 | Therapeutic SAbDab (2026-03-20) |














